Hot Canadian Stocks To Invest In Right Now


Philippine President Rodrigo Duterte said he’s scrapping the acquisition of 16 Canadian Bell helicopters and pledged to end military purchases from countries including the U.S. that impose conditions.

“Do not buy anymore from Canada or from the United States because there is always a condition attached,” Duterte told reporters in Davao City on Friday. He announced the cancellation of the chopper deal with Canada in a subsequent speech. The Canadian government denied the deal had been scrapped.


Canada ordered a review of the agreement a day after it was signed on concern that the aircraft would be used against Filipino rebels, which Duterte didn’t deny. “We will really use these weapons invariably against the rebels and terrorists,” he said Friday, according to a transcript provided by his office. During a forum organized by the Manila Times also in Davao, Duterte said: “We will stop buying. Anything that is arms, do not; Canada is out.”

Hot Canadian Stocks To Invest In Right Now: Silver Wheaton Corp(SLW)


Advisors’ Opinion:

  • [By Rich Duprey]

    Silver Wheaton (NYSE:SLW), of course, is a streamer like Sandstorm and Franco, but it is the largest in the precious-metals industry, and arguably the best-known, because its business model came to define what streaming is. Although it is known primarily for its silver contracts, Silver Wheaton also has sizable gold production that makes it worth your attention.

Hot Canadian Stocks To Invest In Right Now: Rhino Resource Partners LP(RNO)


Advisors’ Opinion:

  • [By Alexis Xydias]

    Investors are regaining confidence, squeezing pessimists who say the economy remains sluggish outside of Germany and point to record-low trading volume as a lack of conviction in the Euro Stoxxs 61 percent rally of the past two years. Besides gains in stocks from Banco Bilbao Vizcaya Argentaria SA to Renault SA (RNO), yields on Spanish and Italian bonds have declined to a two-year low compared with German bunds and the euro has strengthened 4.6 percent to $1.35 in the past six months.

Hot Canadian Stocks To Invest In Right Now: 3M Company(MMM)


Advisors’ Opinion:

  • [By ]

    Cramer was bearish on 3M (MMM) , Fitbit (FIT) and Granite Construction (GVA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded down 1.05% at $210.38. The stock’s 52-week range is $163.85 to $214.57. Volume was about 20% below the daily average of around 1.8 million. The company had no specific news.

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded up 1.51% at $235.69. The stock’s 52-week range is $185.71 to $259.77. Volume was around 1.6 million shares, about a third below the daily average of about 2.4 million. The company had no specific news Thursday.

  • [By ]

    3M (MMM) : “The company said that March might be weak, and that was all she wrote. “

    Granite Construction (GVA) : “No, I’d rather see you in Martin Marietta Materials (MLM) .”

  • [By Paul Ausick]

    3M Company (NYSE: MMM) traded down 2.91% at $216.66 in a 52-week range of $188.62 to $259.77. Volume of about 3.3 million shares was around 30% above the daily average. The company had no specific news Friday.

Hot Canadian Stocks To Invest In Right Now: Valeant Pharmaceuticals International Inc(VRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Healthcare shares rose by 1.68 percent in the US market on Thursday. Top gainers in the sector included Sangamo Therapeutics Inc (NASDAQ: SGMO), Valeant Pharmaceuticals Intl Inc (NYSE: VRX), and Tenet Healthcare Corp (NYSE: THC).

  • [By Ben Levisohn]

    We noted earlier that Valeant Pharmaceuticals International (VRX) has popped today after selling assets for more than $2 billion, beginning what many expect to be just the first round of such sales. BMO’s Gary Nachman notes that Valeant had received “a solid price” for its assets. He explains:

    The first transaction is the sale of Dendreon (Provenge) to Sanpower Group for $820mn in cash. Provenge is a treatment for prostate cancer and is not core to Valeant; thus, we are not surprised by this asset sale. We estimate Provenge sales of $306mn for 2016, which translates to a multiple of ~2.7x.Valeant has been struggling to accelerate Provenge since it acquired the product, and given that the company does not have a real oncology presence we think this deal makes a lot of sense.


    The second transaction is the sale of CeraVe, AcneFree and AMBI to L’Oreal for $1.3bn in cash. These products are OTC skincare brands that we believe are core to Valeant’s dermatology/OTC business; thus, this deal is more surprising to us. However, with annual combined sales for the three products of $168mn, that translates to a multiple of ~7.7x. We think that is a good price and demonstrates Valeant’s willingness to part with some core assets if the valuation makes sense. We view that as a smart business decision given the urgency forValeant to pay down its significant $30bn debt level more aggressively…


    There is still more to go with asset sales, but we view this as a good start for Valeant.

    Shares of Valeant Pharmaceuticals International have gained 5.5% to $16.19 at 2:02 p.m. today. That’s a solid gain, but less thanthe 12% rise in pre-open trading, and the 8.8% rise at 10:27 a.m.

  • [By Kumar Abhishek]

    Shares of specialty pharma company Valeant Pharmaceuticals Intl Inc(NYSE:VRX)have tanked more than 20% in last two trading sessions, breaching the support from the 50 day SMA, after the Laval,Quebec-based company reported its Q4 and FY 2016 earnings on Tuesday, before the market opened. While the earnings itself were better than expected, the guidance for FY 2017 didn’t go down well with investors and wall street, earning the company multiple price target cuts. Valeant reported an adjusted profit of $1.26 a share against analysts’ estimateof $1.21. This was Valeant’s first beat in a long time. Even on the revenue front, the company reported better than expected results. Initially, the stock gained on the report of an earnings beat. However, once the guidance figures came in, the stock tanked. In our earnings preview of Valeant, we had said that the adjusted EBITDA guidance for 2017 will be the key driver of VRX stock after the earnings.

  • [By Ashley Moore]

    The current rally of Valeant Pharmaceuticals International Inc. (NYSE: VRX) is being driven by two things. While investors are viewing these two catalysts as bullish, they are really just temporary solutions.

Hot Canadian Stocks To Invest In Right Now: Safeway Inc.(SWY)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of SUPERVALU underperforming the underperformance ofmid caps Whole Foods Market, Inc (NASDAQ: WFM) and Safeway Inc (NYSE: SWY). while large capKroger Co (NYSE: KR)had outperformed up until the last two years when performance has been more mixed:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap SUPERVALU now underperforming large cap Kroger Co (NYSE: KR) while shares of large cap Whole Foods Market, Inc (NASDAQ: WFM) and mid cap Safeway Inc (NYSE: SWY) appear to be back to where they started at: